The mRNA Monthly—September 2024 Newsletter


Speaking of Mol Bio Podcast

In the latest episode (Season 2, Episode 8) of the Speaking of Mol Bio Podcast, hosts Steve Lewis and Dr. Christian Cobaugh, CEO of Vernal Biosciences, delve into the fascinating world of mRNA technology. The COVID pandemic has brought mRNA into the spotlight, showcasing its immense potential as a therapeutic modality.

Enhanced mRNA Translation Design

This study presents the LEGO method to enhance mRNA translation, crucial for protein and vaccine therapies. By using specific chemical modifications and branched mRNA caps, researchers increased protein production up to tenfold and significantly boosted antibody production in a SARS-CoV-2 vaccine setting. 


Vernal Biosciences mRNA and LNP Analytical Services

Approach to Developing Lipid-Based Systems

Lipid-based drug formulations are promising systems for improving delivery of drugs to ocular tissues, such as retina. Explore the latest advancements in drug delivery with this article “Barcode lipids for absolute quantitation of liposomes in ocular tissues” and gain insights into how these technologies are poised to transform medical treatments and patient care.

Absolute Gene-ius Podcast 

In the latest episode of the Absolute Gene-ius Podcast, hosts Christina Bouwens and Dr. Christian Cobaugh, CEO of Vernal Biosciences, dive into the evolving landscape of mRNA technology. With a mission to enhance access to high-purity mRNA for researchers and drug developers, Christian shares insights from his 15 years at the forefront of mRNA drug discovery. 

Startup Incubator Launch

The University of Vermont and BioLabs have launched a startup incubator, designed to accelerate the growth of new, innovative ventures. Read about the support and resources available to budding entrepreneurs in this collaboration.

Subscribe today